Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

David R. Gandara, Sarah M. Paul, Marcin Kowanetz et al. · Nature Medicine · 2018

Cited by 1,157 works. doi:10.1038/s41591-018-0134-3

Authors

References